Quarterly report pursuant to Section 13 or 15(d)

Stock Warrants (Narrative) (Details)

v3.5.0.2
Stock Warrants (Narrative) (Details)
 9 Months Ended
Sep. 30, 2016
$ / shares
shares
Class of Warrant or Right [Line Items]  
Warrants outstanding (shares) | shares 11,700,000
Common Stock [Member] | Macrophage Therapeutics [Member]  
Class of Warrant or Right [Line Items]  
Exercise price of warrant issued, dollars per share $ 2,000
Outstanding number of warrant to be converted to common stock | shares 300
Minimum [Member]  
Class of Warrant or Right [Line Items]  
Exercise price of warrant issued, dollars per share $ 0.01
Warrant, Outstanding Term 2 months 12 days
Maximum [Member]  
Class of Warrant or Right [Line Items]  
Exercise price of warrant issued, dollars per share $ 3.04
Warrant, Outstanding Term 19 years
Weighted Average [Member]  
Class of Warrant or Right [Line Items]  
Exercise price of warrant issued, dollars per share $ 0.38